BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32381040)

  • 1. A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk.
    Gentles AJ; Hui AB; Feng W; Azizi A; Nair RV; Bouchard G; Knowles DA; Yu A; Jeong Y; Bejnood A; Forgó E; Varma S; Xu Y; Kuong A; Nair VS; West R; van de Rijn M; Hoang CD; Diehn M; Plevritis SK
    Genome Biol; 2020 May; 21(1):107. PubMed ID: 32381040
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zhang W; Bouchard G; Yu A; Shafiq M; Jamali M; Shrager JB; Ayers K; Bakr S; Gentles AJ; Diehn M; Quon A; West RB; Nair V; van de Rijn M; Napel S; Plevritis SK
    Cancer Res; 2018 Jul; 78(13):3445-3457. PubMed ID: 29760045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential importance of protease activated receptor (PAR)-1 expression in the tumor stroma of non-small-cell lung cancer.
    Lin C; Majoor CJ; Roelofs JJ; de Kruif MD; Horlings HM; Borensztajn K; Spek CA
    BMC Cancer; 2017 Feb; 17(1):113. PubMed ID: 28173772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.
    Zhu CQ; Popova SN; Brown ER; Barsyte-Lovejoy D; Navab R; Shih W; Li M; Lu M; Jurisica I; Penn LZ; Gullberg D; Tsao MS
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11754-9. PubMed ID: 17600088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High transforming growth factor β expression represents an important prognostic parameter for surgically resected non-small cell lung cancer.
    Sterlacci W; Wolf D; Savic S; Hilbe W; Schmid T; Jamnig H; Fiegl M; Tzankov A
    Hum Pathol; 2012 Mar; 43(3):339-49. PubMed ID: 21840566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP2 response pattern in human lung fibroblasts predicts outcome in lung adenocarcinomas.
    Rajski M; Saaf A; Buess M
    BMC Med Genomics; 2015 Apr; 8():16. PubMed ID: 25924783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases.
    Paulsen EE; Kilvaer TK; Rakaee M; Richardsen E; Hald SM; Andersen S; Busund LT; Bremnes RM; Donnem T
    Cancer Immunol Immunother; 2017 Nov; 66(11):1449-1461. PubMed ID: 28707078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer.
    Wu F; Fan J; He Y; Xiong A; Yu J; Li Y; Zhang Y; Zhao W; Zhou F; Li W; Zhang J; Zhang X; Qiao M; Gao G; Chen S; Chen X; Li X; Hou L; Wu C; Su C; Ren S; Odenthal M; Buettner R; Fang N; Zhou C
    Nat Commun; 2021 May; 12(1):2540. PubMed ID: 33953163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells.
    Mulvihill MS; Kwon YW; Lee S; Fang LT; Choi H; Ray R; Kang HC; Mao JH; Jablons D; Kim IJ
    PLoS One; 2012; 7(8):e42264. PubMed ID: 22870311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Stromal Periostin Expression in Non-Small Cell Lung Cancer.
    Ratajczak-Wielgomas K; Kmiecik A; Grzegrzołka J; Piotrowska A; Gomulkiewicz A; Partynska A; Pawelczyk K; Nowinska K; Podhorska-Okolow M; Dziegiel P
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinoma.
    Valdmanis PN; Roy-Chaudhuri B; Kim HK; Sayles LC; Zheng Y; Chuang CH; Caswell DR; Chu K; Zhang Y; Winslow MM; Sweet-Cordero EA; Kay MA
    Oncogene; 2015 Jan; 34(1):94-103. PubMed ID: 24317514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma.
    Bischoff P; Trinks A; Obermayer B; Pett JP; Wiederspahn J; Uhlitz F; Liang X; Lehmann A; Jurmeister P; Elsner A; Dziodzio T; Rückert JC; Neudecker J; Falk C; Beule D; Sers C; Morkel M; Horst D; Blüthgen N; Klauschen F
    Oncogene; 2021 Dec; 40(50):6748-6758. PubMed ID: 34663877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth.
    Ding XY; Ding J; Wu K; Wen W; Liu C; Yan HX; Chen C; Wang S; Tang H; Gao CK; Guo LN; Cao D; Li Z; Feng GS; Wang HY; Xu ZF
    Oncogene; 2012 Jun; 31(23):2899-906. PubMed ID: 22002304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 15. Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.
    Kim A; Lim SM; Kim JH; Seo JS
    Front Immunol; 2021; 12():598671. PubMed ID: 33717076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance and biological role of cancer-derived Type I collagen in lung and esophageal cancers.
    Fang S; Dai Y; Mei Y; Yang M; Hu L; Yang H; Guan X; Li J
    Thorac Cancer; 2019 Feb; 10(2):277-288. PubMed ID: 30604926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6.
    Abulaiti A; Shintani Y; Funaki S; Nakagiri T; Inoue M; Sawabata N; Minami M; Okumura M
    Lung Cancer; 2013 Nov; 82(2):204-13. PubMed ID: 24011634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl hydrocarbon receptor activation and overexpression upregulated fibroblast growth factor-9 in human lung adenocarcinomas.
    Wang CK; Chang H; Chen PH; Chang JT; Kuo YC; Ko JL; Lin P
    Int J Cancer; 2009 Aug; 125(4):807-15. PubMed ID: 19358281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
    Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
    Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor microenvironment elicits primary resistance to afatinib through HGF secretion].
    Kang XH; Wang LF; Cao F; Fan FT; Xu ZY
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):732-6. PubMed ID: 24378092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.